Review Questions Tamiflu's Effectiveness
Found on 09 Dec 2009 07:59 GMT
Title: Review Questions Tamiflu's Effectiveness
Category: Health News
Created: 12/8/2009 4:10:00 PM
Last Editorial Review: 12/9/2009
Tamiflu-Resistant Swine Flu Found in Canadian Father
Found on 12 Nov 2009 07:59 GMT
Title: Tamiflu-Resistant Swine Flu Found in Canadian Father
Category: Health News
Created: 11/11/2009 4:10:00 PM
Last Editorial Review: 11/12/2009
Tamiflu-Resistant Swine Flu Passed Person-to-Person in U.S.
Found on 30 Oct 2009 07:59 GMT
Title: Tamiflu-Resistant Swine Flu Passed Person-to-Person in U.S.
Category: Health News
Created: 10/29/2009 2:10:00 PM
Last Editorial Review: 10/30/2009
Oseltamivir-and amantadine-resistant influenza virus A (H1N1).(LETTERS)(Report)
To the Editor: We previously reported detection of double resistance to oseltamivir and amantadine of influenza virus A (H1N1) in Hong Kong during the first half of 2008 (1). Three different strains of A/Hong Kong/2652/2006-like (clade 2C) viruses that carried the S31N mutation in the matrix (M2)
Publication: Emerging Infectious Diseases
Alternative Dosing of Oseltamivir for Specific Patient Populations: Criticall...
Alternative Dosing of Oseltamivir for Specific Patient Populations: Critically Ill and Renally Impaired Abstract & Commentary By Oliver Hsu, PharmD Candidate, at the University of the Pacific. Linda Truong, PharmD Candidate, at the University of the Pacific. Jessica C. Song, MA, PharmD,
Publication: Emergency Medicine Reports
Determination of oseltamivir quality by colorimetric and liquid chromatograph...
We developed a colorimetric and chromatographic assay for oseltamivir to assess the authenticity of Tamiflu (F. Hoffmann-La Roche Ltd., Basel, Switzerland) because of a growing concern about counterfeit oseltamivir. The colorimetric assay is quantitative and relies on an extractable colored
Publication: Emerging Infectious Diseases
Oseltamivir-Resistant Novel Influenza A (H1N1) Virus Infection in Two Immunos...
On August 14, 2009, this report was posted as an MMWR Dispatch on the MMWR website (httpwww.cdc.gov/ mmwr). Novel influenza A (HlNl) virus infection continues to cause illness and death among persons worldwide, lmmunosuppressed patients with influenza virus infection can shed virus for prolonged
Publication: MMWR. Morbidity and Mortality Weekly Report
Oseltamivir-resistant novel influenza a (H1N1) virus infection in two immunos...
On August 14, 2009, this report was posted as an MMWR Dispatch on the MMWR website (httpwww.cdc.gov/mmwr). Novel influenza A (H1N1) virus infection continues to cause illness and death among persons worldwide. Immunosuppressed patients with influenza virus infection can shed virus for prolonged
Publication: Morbidity and Mortality Weekly Report
Oseltamivir
Oseltamivir has come into the limelight after the onset of H1N1-Influenza A ('swine flu') pandemic this year. Influenza infections continue to occur worldwide with adverse outcomes in terms of morbidity and mortality in those who are infected. [1] Oseltamivir is a potent selective inhibitor of the
Publication: Journal of Postgraduate Medicine
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.(RESEARCH)(...
In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007-08
Publication: Emerging Infectious Diseases
Oseltamivir Phosphate Capsules (Tamiflu-Roche Pharmaceuticals).
Pharmacology Update Oseltamivir Phosphate Capsules (TamifluRoche Pharmaceuticals) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD In october, the fda approved oseltamvir (tamifluRoche), the second neuraminidase inhibitor for the treatment of influenza. This comes three months after the
Publication: Internal Medicine Alert
Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).(DISPATCHES)
A high rate of oseltamivir resistance in seasonal influenza virus A (H1N1) infection was reported in Europe in the winter of 2007-08 (1). Of subtype H1N1 isolates tested in 18 European countries, 59 (13.5%) of 437 were resistant to oseltamivir and carried the substitution of histidine by tyrosine
Publication: Emerging Infectious Diseases
Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses.(Report)
Oseltamivir (Tamiflu) Resistance in Seasonal Influenza A (H1N1) Viruses Abstract & commentary By Mary-Louise Scully, MD, Sansum-Santa Barbara Medical Foundation Clinic, Santa Barbara, CA. Dr. Scully reports no financial relationships relevant to this field of study. This article originally
Publication: Hospital Medicine Alert